Please complete the CAPTCHA to continue
@organtransportsystems.com
✓
2 phones found area 972
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Michael Holder is listed as CEO and Board Director in the Life Sciences, Medical Devices, Wellness, and Healthcare (CEO of Sensable Health; and non-executive board director at Cytek Biosciences (NASDAQ:CTKB) and Keyron Medical) at Sensable Health, based in United States. AeroLeads shows a work email signal at organtransportsystems.com, phone signal with area code 972, and a matched LinkedIn profile for Michael Holder.
Michael Holder previously worked as Chief Executive Officer at Sensable Health and Board Member; Chair Audit Committee at Cytek Biosciences. Michael Holder holds Master Of Business Administration (Mba), Corporate Strategy And Finance from The Wharton School.
This section adds company-level context without repeating Michael Holder's masked contact details.
AeroLeads found 1 current-domain work email signal for Michael Holder. Compare company email patterns before reaching out.
Michael Holder has 30+ years of diverse business experience having held 8 board, 4 CEO, 2 PE/venture capital executive, and 5 CFO positions for both public and private companies in the biotech, medtech, pharma, wellness and health tech industries. Mr. Holder’s areas of expertise include corporate strategy, fundraising, business development, M&A, corporate governance, sales & earnings improvement, regulatory, reimbursement, and infrastructure development in public companies on the NASDAQ, ASX, and TSX as well as high growth investor backed private companies. Mr. Holder’s experience includes leadership of a $250M private investment company; leadership, P&L and sales responsibility for a $325M med tech and IT solution hospital supply company; as well as completion of $2.5B+ in M&A transactions, nearly $2B in equity & debt capital transactions including two IPOs, a reverse merger public offering, and 3 corporate exits including a $225M sale as Chairman/CEO.Mr. Holder is currently the CEO of Sensable Health a wellness program that incorporates biology, machine learning, and artificial intelligence into a program to achieve weight loss and healthspan improvement. Mr. Holder is also a board member and Audit Committee Chair of Cytek Biosciences Inc. (NASDAQ:CKTB), a leading cell analysis solutions company; and board director of Keyron Inc., a London, based early-stage medical device company. Mr. Holder is also a Principal in Gloria Consulting Partners LLC, an executive management, business strategy and development, and M&A consulting company.Mr. Holder previously served as CEO of Longevita Bio Pharma Partners, LLC, an advisory firm providing services to global life science and medical device companies. Prior to that, Mr. Holder was CEO and Portfolio Manager of Carolina Longevity Institute, Inc. (CLI), a $250M private investment fund. At CLI, Mr. Holder was responsible for transacting investments and advising portfolio companies in the biotech, health and wellness, and med tech industries. At Organ Transport Systems, Inc., a medical device and biologic company, Mr. Holder was Executive Chairman/CEO and led the recruitment of an industry leading board and completed 4 rounds of fundraising and a Company sale. At Cyphre, Inc. a healthcare cybersecurity company, Mr. Holder assumed a board leadership role in its sale to RigNet Inc. (NASDAQ:RNET). Mr. Holder holds an M.B.A. from the Wharton School, a B.S. in Business Administration from the University of North Carolina (subsequently serving on the Board of Visitors) and previously obtained his CPA.
Listed skills include Leadership, Auditing, Presentation Skills, Business Acquisition, and 46 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Denver, Colorado, Us
Sensable Health offers a wellness solution that incorporates biology, AI, and machine learning to improve and optimize individual healthspan, realize sustainable weight loss, improve nutrition, improve sleep, and lower stress.
Fremont, Ca, Us
Cytek® Biosciences Inc. (NASDAQ:CTKB) is a leading manufacturer and supplier of flow cytometry products and services. Cytek’s compact, affordable instruments and wide ranging support offerings are used by researchers and clinicians all over the world. Flow cytometry is a powerful analytical tool used for identifying and quantifying cellular characteristics on a cell-by-cell basis up to tens of thousands of cells per second. This technology is used in research and clinical studies with various biomedical and therapeutic applications such as investigating the role of the body’s immune system in fighting cancer, diagnosing leukemia and lymphoma, and detecting minimal residual disease in organ transplant patients. Flow cytometry has many advantages over traditional microscopy since it enables the analysis of a greater number of cells in a fraction of the time. At Cytek, we are focused on accelerating the adoption of flow cytometry for one simple reason: to fuel scientific discovery. We have leveraged our highly experienced, best-in-the-business team to bring forth an innovative new class of flow cytometry solutions. These solutions deliver deep biological insights at an affordable price, provide high-end capabilities, and bring simplified workflows to more researchers than ever before. As a company, we also seek to maintain high ethical standards and a culture that values honesty, integrity and transparency in all that we do. Company decisions are driven by what is right for scientific discovery and customer support. We are committed to our employees, to the environment in which we live and to the communities we serve worldwide. Cytek is headquartered in Fremont, California with branch offices and distribution channels across the globe. For more information, visit www.cytekbio.com.Websitehttps://cytekbio.com/IndustryBiotechnology ResearchCompany size501-1,000 employees
Keyron is a London based, medical device and technology platform company developing and commercializing a highly effective treatment of metabolic diseases. Keyron’s patented ForePass™ is an innovative medical device designed to safely reverse type-2 diabetes, as well as NASH, and obesity. The company has already demonstrated a full reversal of insulin resistance in animal studies, and recently published the results in The Lancet EBioMedicine. Keyron has upcoming clinical trials in South America and aims to then carry out further clinical trials in the USA. Its founders, directors, advisors and investors include some of the most well-known and cited professors and KOLs worldwide in the metabolic diseases space. The company is backed by multiple institutional investors based in the USA and EMEA.
Santa Clarita, California, Us
AVITA Medical is a publicly listed (NASDAQ: RCEL, ASX:AVH) regenerative medicine company with a technology platform positioned to address unmet medical needs in burns, acute and chronic wounds, vitiligo, cell and gene therapy, and aesthetics indications. AVITA Therapeutics’ patented and proprietary collection and application technology provides innovative treatment solutions derived from the regenerative properties of a patient’s own skin. The medical devices work by preparing a RES® REGENERATIVE EPIDERMAL SUSPENSION, an autologous suspension comprised of the patient’s skin cells necessary to regenerate natural healthy epidermis. This autologous suspension is then sprayed onto the areas of the patient requiring treatment.
Irvine, California, Us
Global clinical stage biopharmaceutical company with innovative cell and gene immune-oncology therapeutics, including CAR-T, hiTCR-T and CAR-NK plaftorms with 20 overall indications, as well as cGMP facilities and operations in China, India and the US.
Advisory firm providing investment and services to global, clinical-stage life science companies, assuming CXO and board roles, and advising on strategy, fundraising, business development, commercial planning, drug development and regulatory matters.
As non-executive Chairman, led supplement, nutritional product, and wellness company board through private funding round and pre-clinical research activities
Private investment company with a mandate to invest in, acquire and operate biotech, pharma, and medtech companies that improve human health and longevity. Carolina Longevity advises its portfolio companies relative to strategy, M&A, financings, research & regulatory matters, and corporate governance.
Provider of a cyber-security platform created for advanced enterprise data protection. The company's hardware-based encryption features low latency protection for files at rest and in transit for both public and private cloud enabling companies to have higher levels of granularity and control than previously seen in the market.Led board through CEO transition and sale of company to RigNet (NASDAQ:RNET)
Medical device and pharma solution company which developed the LifeCradle device and solution that preserves, monitors and transports organs to be used in transplantation.
Charlotte, Nc, Us
Medical equipment and IT product and services subsidiary of leading group purchasing organization named to the Fortune Best Company to Work List (100 best companies to work for in the United States).
Quick answers generated from the profile data available on this page.
Michael Holder works for Sensable Health.
Michael Holder is listed as CEO and Board Director in the Life Sciences, Medical Devices, Wellness, and Healthcare (CEO of Sensable Health; and non-executive board director at Cytek Biosciences (NASDAQ:CTKB) and Keyron Medical) at Sensable Health.
AeroLeads has found 1 work email signal at @organtransportsystems.com for Michael Holder at Sensable Health.
AeroLeads has found 2 phone signal(s) with area code 972 for Michael Holder at Sensable Health.
Michael Holder is based in United States while working with Sensable Health.
Michael Holder has worked for Sensable Health, Cytek Biosciences, Keyron Medical Technology, Avita Medical, and Immunecyte, Inc..
You can use AeroLeads to view verified contact signals for Michael Holder at Sensable Health, including work email, phone, and LinkedIn data when available.
Michael Holder holds Master Of Business Administration (Mba), Corporate Strategy And Finance from The Wharton School.
Michael Holder is listed with skills including Leadership, Auditing, Presentation Skills, Business Acquisition, Leadership Skills, Team Building, Accounting, and Sec Financial Reporting.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts